Back to Search
Start Over
Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
- Source :
-
Blood cancer journal [Blood Cancer J] 2023 Sep 27; Vol. 13 (1), pp. 152. Date of Electronic Publication: 2023 Sep 27. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 2044-5385
- Volume :
- 13
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Blood cancer journal
- Accession number :
- 37752114
- Full Text :
- https://doi.org/10.1038/s41408-023-00923-6